A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma

Andrew Spencer; Patricia Walker; Parisa Asvadi; Douglas H. Campbell; Kate Reed; Ben R. Herbert; Edmond J. Breen; Michael C. Copeman; Rosanne D. Dunn

doi:10.1038/s41408-019-0217-5

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma

Andrew Spencer^*, Patricia Walker, Parisa Asvadi, Douglas H. Campbell, Kate Reed, Ben R. Herbert, Edmond J. Breen, Michael C. Copeman, Rosanne D. Dunn

^*Corresponding author for this work

Australian Proteome Analysis Facility (APAF)

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

53 Downloads (Pure)

Original language	English
Article number	58
Number of pages	5
Journal	Blood Cancer Journal
Volume	9
Issue number	8
DOIs	https://doi.org/10.1038/s41408-019-0217-5
Publication status	Published - 31 Jul 2019

Bibliographical note

Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Access to Document

10.1038/s41408-019-0217-5

Publisher version (open access)Final published version, 596 KBLicence: CC BY

Cite this

@article{26a743817bd042ea94396ff6c244ca1d,

title = "A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma",

author = "Andrew Spencer and Patricia Walker and Parisa Asvadi and Campbell, {Douglas H.} and Kate Reed and Herbert, {Ben R.} and Breen, {Edmond J.} and Copeman, {Michael C.} and Dunn, {Rosanne D.}",

note = "Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher. ",

year = "2019",

month = jul,

day = "31",

doi = "10.1038/s41408-019-0217-5",

language = "English",

volume = "9",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Springer, Springer Nature",

number = "8",

}

TY - JOUR

T1 - A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma

AU - Spencer, Andrew

AU - Walker, Patricia

AU - Asvadi, Parisa

AU - Campbell, Douglas H.

AU - Reed, Kate

AU - Herbert, Ben R.

AU - Breen, Edmond J.

AU - Copeman, Michael C.

AU - Dunn, Rosanne D.

N1 - Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/7/31

Y1 - 2019/7/31

UR - http://www.scopus.com/inward/record.url?scp=85069961620&partnerID=8YFLogxK

U2 - 10.1038/s41408-019-0217-5

DO - 10.1038/s41408-019-0217-5

M3 - Letter

C2 - 31366914

AN - SCOPUS:85069961620

SN - 2044-5385

VL - 9

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 8

M1 - 58

ER -

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma

Bibliographical note

Access to Document

Other files and links

Cite this